
MicroSurvey
Online, on-demand market research connecting you to the right healthcare stakeholders.
More About MicroSurvey
November 9, 2020
Given the recent uptick in COVID-19 cases in the US, many InCrowd panelists have been reporting that they do not expect things to return to normal until a vaccine is developed and disseminated. In order to deepen our understanding of the COVID-19 vaccine landscape, we surveyed infectious disease specialists across the country to get their perception and predictions on the efficacy, impact, and competitive landscape of COVID-19 vaccines.*
* Please note, views in this survey reflect opinions only as reported by responding physicians.
Methodology:
InCrowd’s other COVID-19 Tracking Reports: